Literature DB >> 21803993

Structure-based modification of a Clostridium difficile-targeting endolysin affects activity and host range.

Melinda J Mayer1, Vasiliki Garefalaki, Rebecca Spoerl, Arjan Narbad, Rob Meijers.   

Abstract

Endolysin CD27L causes cell lysis of the pathogen Clostridium difficile, a major cause of nosocomial infection. We report a structural and functional analysis of the catalytic activity of CD27L against C. difficile and other bacterial strains. We show that truncation of the endolysin to the N-terminal domain, CD27L1-179, gave an increased lytic activity against cells of C. difficile, while the C-terminal region, CD27L180-270, failed to produce lysis. CD27L1-179 also has increased activity against other bacterial species that are targeted by the full-length protein and in addition was able to lyse some CD27L-insensitive strains. However, CD27L1-179 retained a measure of specificity, failing to lyse a wide range of bacteria. The use of green fluorescent protein (GFP)-labeled proteins demonstrated that both CD27L and CD27L1-179 bound to C. difficile cell walls. The crystal structure of CD27L1-179 confirms that the enzyme is a zinc-dependent N-acetylmuramoyl-l-alanine amidase. A structure-based sequence analysis allowed us to identify four catalytic residues, a proton relay cascade, and a substrate binding pocket. A BLAST search shows that the closest-related amidases almost exclusively target Clostridia. This implied that the catalytic domain alone contained features that target a specific bacterial species. To test this hypothesis, we modified Leu 98 to a Trp residue which is found in an endolysin from a bacteriophage of Listeria monocytogenes (PlyPSA). This mutation in CD27L resulted in an increased activity against selected serotypes of L. monocytogenes, demonstrating the potential to tune the species specificity of the catalytic domain of an endolysin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21803993      PMCID: PMC3187396          DOI: 10.1128/JB.00439-11

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  40 in total

1.  Multiparametric scaling of diffraction intensities.

Authors:  Zbyszek Otwinowski; Dominika Borek; Wladyslaw Majewski; Wladek Minor
Journal:  Acta Crystallogr A       Date:  2003-04-25       Impact factor: 2.290

2.  Macromolecular TLS refinement in REFMAC at moderate resolutions.

Authors:  Martyn D Winn; Garib N Murshudov; Miroslav Z Papiz
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

3.  ESPript/ENDscript: Extracting and rendering sequence and 3D information from atomic structures of proteins.

Authors:  Patrice Gouet; Xavier Robert; Emmanuel Courcelle
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

4.  Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain.

Authors:  Stephen C Becker; Juli Foster-Frey; Angeline J Stodola; Daniel Anacker; David M Donovan
Journal:  Gene       Date:  2009-05-05       Impact factor: 3.688

5.  Molecular replacement with MOLREP.

Authors:  Alexei Vagin; Alexei Teplyakov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin.

Authors:  Melinda J Mayer; Arjan Narbad; Michael J Gasson
Journal:  J Bacteriol       Date:  2008-08-15       Impact factor: 3.490

Review 8.  Clostridium difficile infection: new developments in epidemiology and pathogenesis.

Authors:  Maja Rupnik; Mark H Wilcox; Dale N Gerding
Journal:  Nat Rev Microbiol       Date:  2009-07       Impact factor: 60.633

9.  Gamma-phage lysin PlyG sequence-based synthetic peptides coupled with Qdot-nanocrystals are useful for developing detection methods for Bacillus anthracis by using its surrogates, B. anthracis-Sterne and B. cereus-4342.

Authors:  Shilpakala Sainathrao; Ketha V Krishna Mohan; Chintamani Atreya
Journal:  BMC Biotechnol       Date:  2009-07-22       Impact factor: 2.563

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more
  46 in total

Review 1.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

2.  Structural and biochemical analyses of Mycobacterium tuberculosis N-acetylmuramyl-L-alanine amidase Rv3717 point to a role in peptidoglycan fragment recycling.

Authors:  Daniil M Prigozhin; Daniela Mavrici; John P Huizar; Hilary J Vansell; Tom Alber
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

3.  Fecal microbiota transplantation to fight Clostridium difficile infections and other intestinal diseases.

Authors:  Karin Moelling; Felix Broecker
Journal:  Bacteriophage       Date:  2016-10-21

4.  Using a Novel Lysin To Help Control Clostridium difficile Infections.

Authors:  Qiong Wang; Chad W Euler; Aurelia Delaune; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

5.  Structure-function analysis of the LytM domain of EnvC, an activator of cell wall remodelling at the Escherichia coli division site.

Authors:  Nick T Peters; Cécile Morlot; Desirée C Yang; Tsuyoshi Uehara; Thierry Vernet; Thomas G Bernhardt
Journal:  Mol Microbiol       Date:  2013-07-23       Impact factor: 3.501

6.  A conformational switch controls cell wall-remodelling enzymes required for bacterial cell division.

Authors:  Desirée C Yang; Kemin Tan; Andrzej Joachimiak; Thomas G Bernhardt
Journal:  Mol Microbiol       Date:  2012-07-11       Impact factor: 3.501

7.  Bacteriophage PBC1 and its endolysin as an antimicrobial agent against Bacillus cereus.

Authors:  Minsuk Kong; Sangryeol Ryu
Journal:  Appl Environ Microbiol       Date:  2015-01-16       Impact factor: 4.792

Review 8.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

9.  Characterization of AmiBA2446, a novel bacteriolytic enzyme active against Bacillus species.

Authors:  Krunal K Mehta; Elena E Paskaleva; Saba Azizi-Ghannad; Daniel J Ley; Martin A Page; Jonathan S Dordick; Ravi S Kane
Journal:  Appl Environ Microbiol       Date:  2013-07-19       Impact factor: 4.792

10.  Newly identified bacteriolytic enzymes that target a wide range of clinical isolates of Clostridium difficile.

Authors:  Krunal K Mehta; Elena E Paskaleva; Xia Wu; Navdeep Grover; Ruchir V Mundra; Kevin Chen; Yongrong Zhang; Zhiyong Yang; Hanping Feng; Jonathan S Dordick; Ravi S Kane
Journal:  Biotechnol Bioeng       Date:  2016-06-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.